PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
503.87 - 512.55
344.79 - 555.45
23.62M / 20.39M (Avg.)
37.30 | 13.67
Helps investors judge whether earnings growth is driven by sustainable operations or temporary factors. Consistent, organic income expansion can justify a higher intrinsic value for patient, long-term investors.
2.27%
Revenue growth below 50% of ORCL's 43.50%. Michael Burry would check for competitive disadvantage risks.
-8.49%
Cost reduction while ORCL shows 12.34% growth. Joel Greenblatt would examine competitive advantage.
2.81%
Gross profit growth below 50% of ORCL's 55.69%. Michael Burry would check for structural issues.
0.53%
Margin expansion below 50% of ORCL's 8.49%. Michael Burry would check for structural issues.
24.45%
Similar R&D growth to ORCL's 27.77%. Walter Schloss would investigate industry innovation requirements.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
1.74%
Operating expenses growth less than half of ORCL's 43.28%. David Dodd would verify sustainability.
0.98%
Total costs growth less than half of ORCL's 32.19%. David Dodd would verify sustainability.
No Data
No Data available this quarter, please select a different quarter.
-23.81%
D&A reduction while ORCL shows 8.95% growth. Joel Greenblatt would examine efficiency.
-0.93%
EBITDA decline while ORCL shows 69.54% growth. Joel Greenblatt would examine position.
1.25%
EBITDA margin growth below 50% of ORCL's 24.19%. Michael Burry would check for structural issues.
4.65%
Operating income growth below 50% of ORCL's 84.66%. Michael Burry would check for structural issues.
2.33%
Operating margin growth below 50% of ORCL's 28.68%. Michael Burry would check for structural issues.
-44.44%
Other expenses reduction while ORCL shows 65.48% growth. Joel Greenblatt would examine advantage.
-0.46%
Pre-tax income decline while ORCL shows 84.51% growth. Joel Greenblatt would examine position.
-2.67%
Pre-tax margin decline while ORCL shows 28.58% growth. Joel Greenblatt would examine position.
-0.33%
Tax expense reduction while ORCL shows 89.29% growth. Joel Greenblatt would examine advantage.
-0.53%
Net income decline while ORCL shows 82.05% growth. Joel Greenblatt would examine position.
-2.74%
Net margin decline while ORCL shows 26.86% growth. Joel Greenblatt would examine position.
36.36%
Similar EPS growth to ORCL's 39.00%. Walter Schloss would investigate industry trends.
No Data
No Data available this quarter, please select a different quarter.
-34.56%
Share count reduction while ORCL shows 4.76% change. Joel Greenblatt would examine strategy.
-0.55%
Diluted share reduction while ORCL shows 4.76% change. Joel Greenblatt would examine strategy.